topicValerian Sleep Latency Meta-Analysis
claimMedicinal plants and their preparations have gained increased interest—not only because of their use in traditional medicine, but also owing to growing preclinical and clinical data indicating their potential efficacy within the CNS [,].
evidence level3
citationMielczarek Lidia (2026)
sourceNeuroprotective and Neuromodulatory Potential of Valeriana officinalis , Passiflora incarnata , and Ginkgo biloba : Efficacy, Safety, and Regulatory Aspects
topicValerian Sleep Latency Meta-Analysis
claimPotential clinical benefits are included, while the risk of adverse effects is also described, and legal regulations surrounding the possibility of using the raw materials as dietary supplements are mentioned, along with safety assessments at the European level.
evidence level3
citationMielczarek Lidia (2026)
sourceNeuroprotective and Neuromodulatory Potential of Valeriana officinalis , Passiflora incarnata , and Ginkgo biloba : Efficacy, Safety, and Regulatory Aspects
topicValerian Sleep Latency Meta-Analysis
claimIts aim is to summarize and critically discuss the clinical, toxicological, and regulatory evidence regarding,, andin disorders of the central nervous system, rather than to answer a single predefined question through a systematic protocol.
evidence level3
citationMielczarek Lidia (2026)
sourceNeuroprotective and Neuromodulatory Potential of Valeriana officinalis , Passiflora incarnata , and Ginkgo biloba : Efficacy, Safety, and Regulatory Aspects
topicValerian Sleep Latency Meta-Analysis
claimbiloba Neurological and neuropsychiatric disorders (NDs), which include ADHD, Parkinson’s disease, migraine, insomnia, anxiety disorders, and dementia, are a varied group of conditions that involve the loss of neurons and worsening degeneration of various areas of the nervous system.
evidence level3
citationMielczarek Lidia (2026)
sourceNeuroprotective and Neuromodulatory Potential of Valeriana officinalis , Passiflora incarnata , and Ginkgo biloba : Efficacy, Safety, and Regulatory Aspects
topicValerian Sleep Latency Meta-Analysis
claimFailure to meet the recommended 7-9 hours of restful sleep per night is known to increase the risk of several health conditions, reason why regular and adequate sleep should be seen as a priority instead of an unnecessary commodity easily traded as required by the commitments of our busy lives.
evidence level4
citationConti F (2026)
sourceDietary Protocols to Promote and Improve Restful Sleep: A Narrative Review.
topicValerian Sleep Latency Meta-Analysis
claimWhile both the quantity and the quality of sleep can be largely improved with relatively straightforward practices dictated by good sleep hygiene, emerging research suggests that dietary and supplementation protocols focused on certain foods, nutrients, and biochemical compounds with sleep-promoting properties can act as subsidiary sleep aids in complementing these behavioral changes.
evidence level4
citationConti F (2026)
sourceDietary Protocols to Promote and Improve Restful Sleep: A Narrative Review.
topicValerian Sleep Latency Meta-Analysis
claimThe scope of this narrative review is to summarize the available evidence on the potential benefits of selected nutraceuticals in the context of circadian rhythm and sleep disturbances, namely melatonin, magnesium, omega-3 fatty acids, tart cherry juice, kiwifruit, apigenin, valerian root, L-theanine, glycine, ashwagandha, myoinositol, Rhodiola rosea, and phosphatidylserine.
evidence level4
citationConti F (2026)
sourceDietary Protocols to Promote and Improve Restful Sleep: A Narrative Review.
topicValerian Sleep Latency Meta-Analysis
claimHumans spend approximately one third of their life asleep but, as counterintuitive as it may sound, sleep is far from being a quiet state of inactivity.
evidence level4
citationConti F (2026)
sourceDietary Protocols to Promote and Improve Restful Sleep: A Narrative Review.